Other OTC Pharmaceuticals (Pharmacies) - Worldwide

  • Worldwide
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$28.48bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.22%, resulting in a market volume of US$29.90bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.68 are generated in 2024.

Key regions: United Kingdom, Canada, France, Europe, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in worldwide has been experiencing significant growth in recent years. This can be attributed to various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences play a crucial role in shaping the development of the Other OTC Pharmaceuticals (Pharmacies) market. Consumers are increasingly seeking convenience and accessibility when it comes to purchasing healthcare products. This has led to a rise in demand for over-the-counter pharmaceuticals, as they can be easily obtained without a prescription. Additionally, customers are becoming more health-conscious and are actively seeking out self-care options. This has further fueled the demand for OTC pharmaceuticals, as they provide a quick and convenient solution for common health issues. Trends in the market also contribute to the growth of the Other OTC Pharmaceuticals (Pharmacies) market. One notable trend is the increasing availability of OTC products online. With the rise of e-commerce, consumers now have the option to purchase OTC pharmaceuticals from the comfort of their own homes. This has expanded the reach of the market, allowing customers from remote areas to access a wide range of products. Another trend is the growing popularity of natural and herbal remedies. Consumers are increasingly seeking alternative treatments and are turning to OTC pharmaceuticals that are derived from natural sources. This trend has opened up new opportunities for market players to introduce innovative products and cater to the changing preferences of customers. Local special circumstances can also influence the development of the Other OTC Pharmaceuticals (Pharmacies) market in specific countries. For example, in countries with an aging population, there is a higher demand for OTC pharmaceuticals that cater to the needs of older adults. This includes products for managing chronic conditions such as arthritis, diabetes, and cardiovascular diseases. Additionally, in countries with a high prevalence of certain health issues, such as allergies or respiratory problems, there is a greater demand for OTC pharmaceuticals that target these specific conditions. Market players need to be aware of these local special circumstances and tailor their product offerings accordingly to meet the needs of the local population. Underlying macroeconomic factors also play a role in the development of the Other OTC Pharmaceuticals (Pharmacies) market. Factors such as economic growth, rising disposable incomes, and increasing healthcare expenditure contribute to the overall growth of the market. As economies grow and incomes rise, consumers have more purchasing power and are willing to spend on healthcare products. Additionally, increasing healthcare expenditure by governments and private insurers further boosts the demand for OTC pharmaceuticals. These macroeconomic factors create a favorable environment for market players to expand their operations and tap into new markets. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in worldwide is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. As consumers seek convenience and accessibility, the demand for OTC pharmaceuticals continues to grow. Market players need to stay abreast of the latest trends and cater to the specific needs of local populations to capitalize on the opportunities in this evolving market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)